Literature DB >> 7575537

Reversible inhibition of NADPH-cytochrome P450 reductase by alpha-lipoic acid.

I A Slepneva1, S V Sergeeva, V V Khramtsov.   

Abstract

NADPH-cytochrome-P450 reductase both purified from rat hepatic microsomes and involved in microsomal fraction was inactivated by treatment with alpha-lipoic acid. Since alpha-lipoic acid contains disulfide bond, it reacts with SH-groups of the reductase via the reaction of thiol-disulfide exchange resulting in the loss of the enzyme reducing activity. NADP+ completely protected reductase from the inactivation. The modification of reductase was reversible: the modified enzyme was partially reactivated with dithiothreitol and dihydrolipoic acid in the case when cytochrome c was used as a substrate of reductase. In the case when inorganic substrate, K3Fe(CN)6, was used for assay the activity of modified reductase no reactivation was observed. It was found that the order of the reaction of inactivation of membrane-bound microsomal reductase is equal to 1.2 +/- 0.2, which is in an agreement with pseudo-first order kinetics, and the second-order-rate constant of 26 M-1min-1. The results have shown that well known therapeutic agent alpha-lipoic acid is an efficient inhibitor of both purified and microsomal reductase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575537     DOI: 10.1006/bbrc.1995.2420

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  α-Lipoic acid protects mitochondrial enzymes and attenuates lipopolysaccharide-induced hypothermia in mice.

Authors:  Sylvia Hiller; Robert DeKroon; Longquan Xu; Jennifer Robinette; Witold Winnik; Oscar Alzate; Stephen Simington; Nobuyo Maeda; Xianwen Yi
Journal:  Free Radic Biol Med       Date:  2014-03-24       Impact factor: 7.376

2.  Molecular mechanisms of lipoic acid modulation of T-type calcium channels in pain pathway.

Authors:  Woo Yong Lee; Peihan Orestes; Janelle Latham; Ajit K Naik; Michael T Nelson; Iuliia Vitko; Edward Perez-Reyes; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  J Neurosci       Date:  2009-07-29       Impact factor: 6.167

3.  Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes.

Authors:  Lu Gan; Lisa L von Moltke; Lauren A Trepanier; Jerold S Harmatz; David J Greenblatt; Michael H Court
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

4.  Dihydro-alpha-lipoic acid has more potent cytotoxicity than alpha-lipoic acid.

Authors:  Masao Yamasaki; Akiko Kawabe; Kentaro Nishimoto; Harishkumar Madhyastha; Yoichi Sakakibara; Masahito Suiko; Takeaki Okamoto; Taiji Suda; Kenzo Uehira; Kazuo Nishiyama
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-01-01       Impact factor: 2.416

5.  Comparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.

Authors:  Bo Wen; Kevin J Coe; Peter Rademacher; William L Fitch; Mario Monshouwer; Sidney D Nelson
Journal:  Chem Res Toxicol       Date:  2008-12       Impact factor: 3.739

6.  Nitroreduction of flutamide by Cunninghamella elegans NADPH: Cytochrome P450 reductase.

Authors:  Mohd Faheem Khan; Cormac D Murphy
Journal:  Biochem Biophys Rep       Date:  2022-01-17

Review 7.  Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches.

Authors:  Marie Stiborová; Eva Frei; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.